Taiwan-based vaccine maker Medigen will conduct a Phase 3 clinical trial for its COVID-19 vaccine in Europe once it has received approval from European authorities, which would help pave the way for its entry into European and other international markets, the company announced Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Magnitude 5.2 earthquake shakes northeastern Taiwan
08/15/2026 07:43 PM - Society
Taiwan High Speed Rail to review fares in 2027
08/15/2026 07:10 PM - Business
CPC to keep domestic gasoline, diesel prices steady next week
08/15/2026 06:32 PM - Society
Hornets kill 2 hikers, leave 1 with severe kidney damage in Pingtung
08/15/2026 05:57 PM - Politics
European parliamentary staffers visit Taiwan under values program
08/15/2026 05:30 PM